Oncology & Cancer
Updates: MET targeted therapy for EXON 14 mutations in lung cancer
A new editorial paper titled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published in Oncotarget.
Sep 11, 2023
0
13
Page 2 - News tagged with tyrosine
Medical research
A cell surface marker for identifying tumor-initiating cells in pancreatic cancer
Tumor-initiating cells, or cancer stem cells, are gaining attention in cancer therapy, as they can travel through the body and cause cancerous tumors at other sites through metastasis. These cells also may cause resistance ...
Jul 5, 2023
0
0
Medications
FDA approves Litfulo for teens, adults with alopecia areata
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
Medications
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia
First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic lymphocytic leukemia (CLL) whether or not their cancer harbored high-risk genetic features typically ...
Jun 7, 2023
0
3
Oncology & Cancer
New leukemia treatment-response 'crystal ball' discovered using AI
Scientists at Duke-NUS Medical School, A*STAR's Genome Institute of Singapore (GIS), Singapore General Hospital (SGH) and their colleagues in Singapore have used artificial intelligence (AI) to accelerate the discovery of ...
Jun 1, 2023
0
2
Arthritis & Rheumatism
Does brepocitinib benefit patients with psoriatic arthritis?
Brepocitinib is an oral drug that inhibits certain enzymes involved in inflammation—called tyrosine kinase 2 and Janus kinase 1—and is being tested for the treatment of several immunological diseases. A phase IIb randomized ...
May 17, 2023
0
2
Oncology & Cancer
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation
A new research paper was published in Oncotarget's, titled "Differential silencing of STAT3 isoforms leads to changes in STAT3 activation."
Apr 26, 2023
0
3
Oncology & Cancer
The impact of cortactin in cancer progression
A new editorial paper titled " Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway" has been published in Oncotarget.
Apr 4, 2023
0
24
Oncology & Cancer
National prostate cancer trial currently testing therapy based on molecular discovery
A new prostate cancer therapy in clinical trials could treat patients resistant to treatment through targeting the disease on a molecular level, based on new Cleveland Clinic research.
Jan 17, 2023
0
29
Medications
Drug approved to help young patients battle a rare cancer
Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.
Jan 2, 2023
0
4
